17275070

Source:http://linkedlifedata.com/resource/pubmed/id/17275070

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0038953, umls-concept:C0220901, umls-concept:C0332307, umls-concept:C1306837
pubmed:issue	2
pubmed:dateCreated	2007-2-26
pubmed:abstractText	To evaluate the prognostic significance of subtyping papillary renal cell carcinoma (PRCC) into type 1 and type 2 tumors.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0366151
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1527-9995
pubmed:author	pubmed-author:Amsellem-OuazanaDelphineD, pubmed-author:ConquySophieS, pubmed-author:DebréBernardB, pubmed-author:ElieCarolineC, pubmed-author:FlamThierryT, pubmed-author:PignotGéraldineG, pubmed-author:VieillefondAnnickA, pubmed-author:ZerbibMarcM
pubmed:issnType	Electronic
pubmed:volume	69
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	230-5
pubmed:meshHeading	pubmed-meshheading:17275070-Age Factors, pubmed-meshheading:17275070-Aged, pubmed-meshheading:17275070-Biopsy, Needle, pubmed-meshheading:17275070-Carcinoma, Renal Cell, pubmed-meshheading:17275070-Cohort Studies, pubmed-meshheading:17275070-Disease-Free Survival, pubmed-meshheading:17275070-Female, pubmed-meshheading:17275070-Humans, pubmed-meshheading:17275070-Immunohistochemistry, pubmed-meshheading:17275070-Kidney Neoplasms, pubmed-meshheading:17275070-Male, pubmed-meshheading:17275070-Middle Aged, pubmed-meshheading:17275070-Multivariate Analysis, pubmed-meshheading:17275070-Neoplasm Staging, pubmed-meshheading:17275070-Nephrectomy, pubmed-meshheading:17275070-Prognosis, pubmed-meshheading:17275070-Retrospective Studies, pubmed-meshheading:17275070-Risk Assessment, pubmed-meshheading:17275070-Sex Factors, pubmed-meshheading:17275070-Survival Analysis
pubmed:year	2007
pubmed:articleTitle	Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
pubmed:affiliation	Department of Urology, Université Paris-Descartes Faculté de Médecine, AP-HP Hôpital Cochin, Paris, France.
pubmed:publicationType	Journal Article